{"context":{"query":">>pharmgkb_gene>>pharmgkb","source_dataset":"pharmgkb_gene","target_dataset":"pharmgkb"},"stats":{"queried":1,"total":19,"mapped":1},"pagination":{"has_next":false},"schema":"id|name|type|clinical_annotation_count|variant_annotation_count|pathway_count","mappings":[{"input":"PA30196","source":"PA30196|KRAS proto-oncogene, GTPase","targets":["PA10040|cetuximab|Drug|15|87|1","PA128406956|fluorouracil|Drug|197|1031|2","PA162373091|panitumumab|Drug|6|39|1","PA165946873|vemurafenib|Drug|0|2|1","PA166114911|dabrafenib|Drug|0|3|1","PA166114943|regorafenib|Drug|1|13|2","PA166115364|trametinib|Drug|0|0|0","PA166124615|pembrolizumab|Drug|0|12|0","PA166129522|nivolumab|Drug|0|11|0","PA166179872|encorafenib|Drug|0|0|0","PA166182718|ipilimumab|Drug|0|9|0","PA166184558|ramucirumab|Drug|0|0|0","PA166184566|tipiracil / trifluridine|Drug|0|0|0","PA166225141|tucatinib|Drug|0|0|0","PA166246421|adagrasib|Drug|0|0|0","PA166246441|sotorasib|Drug|0|0|1","PA166328842|fruquintinib|Drug|0|0|0","PA450085|irinotecan|Prodrug|54|434|2","PA451996|azacitidine|Drug|0|6|0"]}]}